← All stocks

Opus Genetics, Inc.

IRD Net selling
CIK 0001228627 #3431 in the set updated 17 Sep 2026
Bought (12 mo)
$323.69K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$16.59M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$16.59M
17 of 17 sales
Net
−$16.27M
−$16.27M against sales at will

By person

16 insiders · 21 transactions
15.5×

Dr. George Magrath holds 15.5 times base salary in stock. $9.31M of shares against $598.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Dr. George Magrath last reported holding, valued at $4.54, the price Common Stock was last bought or sold at on the open market here, on 3 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Foundation Fighting Blindness Retinal Degeneration Fund entity
Director
$16.00M (2)
−$16.00M
3,792,171
$17.23M
+47.9%
Gallagher Cam
Director
$323.69K (2)
+$323.69K
2,966,111
$13.48M
+1,753%
Magrath George
Chief Executive Officer
$204.90K (3)
−$204.90K
2,048,485
$9.31M
+376.4%
Gagnon Robert E.
Chief Financial Officer
$190.81K (3)
−$190.81K
556,375
$2.53M
YERXA BENJAMIN R
President
$61.19K (2)
−$61.19K
704,106
$3.20M
Jayagopal Ashwath
Chief Scientific & Dev. Ofc.
$58.20K (2)
−$58.20K
509,233
$2.31M
+548.7%
SCHACHLE JOSEPH K
Chief Operating Officer
$57.70K (3)
−$57.70K
291,440
$1.32M
+14,472%
Zaremba Rabourn Amy
Head of Fin. Quality Assurance
$23.31K (2)
−$23.31K
188,671
$857.19K
+128.3%
Rodgers Richard J
Director
343,022
$1.56M
+43.4%
Ainsworth Sean
Director
321,692
$1.46M
+264.1%
MANUSO JAMES S J
Director
317,318
$1.44M
+140.3%
Bennett Jean
Director
259,019
$1.18M
Benton Susan
Director
243,894
$1.11M
+74.2%
Jhaveri Nirav S.
Chief Financial Officer
194,293
$882.73K
+29.5%
Hoffmann Bernhard
SVP of Corp. Dev.
185,446
$842.54K
+14.0%
Graves Adrienne L
Director
127,514
$579.33K

No percentages here. This company's share count has moved by a factor of 2.6 over the window, from 31,568,457 to 83,195,823 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
Magrath George
9 Sep 2026
Chief Executive Officer
Exercised, kept
392,157
$1.15
$450.98K
Gallagher Cam
8 Sep 2026
Director
Exercised, kept
784,314
$1.15
$901.96K
Gagnon Robert E.
3 Sep 2026
Chief Financial Officer
Sell
28,000
$4.54
$127.21K
Gagnon Robert E.
23 Jul 2026
Chief Financial Officer
Sell
7,783
$2.95
$22.94K
Magrath George
23 Jul 2026
Chief Executive Officer
Sell
9,475
$2.95
$27.93K
SCHACHLE JOSEPH K
23 Jul 2026
Chief Operating Officer
Sell
4,644
$2.94
$13.65K
YERXA BENJAMIN R
23 Jul 2026
President
Sell
7,429
$2.97
$22.06K
Foundation Fighting Blindness Retinal Degeneration Fund
18 May 2026
Director
Sell
1,700,000
$4.35
$7.40M
Gagnon Robert E.
23 Apr 2026
Chief Financial Officer
Sell
7,842
$5.18
$40.66K
Jayagopal Ashwath
23 Apr 2026
Chief Scientific & Dev. Ofc.
Sell
7,542
$5.19
$39.16K
Magrath George
23 Apr 2026
Chief Executive Officer
Sell
9,511
$5.22
$49.65K
Zaremba Rabourn Amy
23 Apr 2026
Head of Fin. Quality Assurance
Sell
1,641
$5.20
$8.54K
SCHACHLE JOSEPH K
23 Apr 2026
Chief Operating Officer
Sell
4,697
$5.22
$24.52K
YERXA BENJAMIN R
23 Apr 2026
President
Sell
7,470
$5.24
$39.12K
Jayagopal Ashwath
16 Mar 2026
Chief Scientific & Dev. Ofc.
Sell
3,719
$5.12
$19.05K
Magrath George
16 Mar 2026
Chief Executive Officer
Sell
24,438
$5.21
$127.33K
Zaremba Rabourn Amy
16 Mar 2026
Head of Fin. Quality Assurance
Sell
2,816
$5.25
$14.77K
SCHACHLE JOSEPH K
16 Mar 2026
Chief Operating Officer
Sell
3,719
$5.25
$19.53K
Gallagher Cam
29 Dec 2025
Director
Buy indirect
83,000
$1.97
$163.42K
Gallagher Cam
29 Dec 2025
Director
Buy
81,000
$1.98
$160.27K
Foundation Fighting Blindness Retinal Degeneration Fund
9 Dec 2025
Director
Sell
4,000,000
$2.15
$8.60M

What was left out

Form 4 filings counted 43
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 17
Transactions with no price 0
Shares from compensation/vesting 3,727,983
History held since 24 Jan 2017